There IS such a thing, if some doctors could get over thinking it only happens to HIV patients.

I don't know if either of these is the most respectable source, but they do both generally provide references.

Candida in the Human Lung Written by Luke Curtis, MD MS CIH

http://www.knowthecause.com/index.php/health-blog/doctors-and-trade-professionals/4487-candida-in-the-human-lung

In people with reasonably functional immune systems, Candida can still cause a number of health problems including digestive problems, increased risk for allergy, and infections to the urinary and sex organs...

The role of Candida colonization/ infection in the human lung is not well understood. Candida species colonize the lungs of about half of all humans, the majority of which are asymptomatic1. A study of 803 intensive care unit (ICU) patients reported that Candida lung colonization was associated with significantly longer duration of mechanical ventilation, significantly longer hospital stay, and significantly higher rates of Pneumonia due to Pseudomonas aeruginosa bacteria2. Another study reported that Candida colonization was associated with a 2.5 fold increased risk of death in patients with VAP = ventilator associated pneumonia 3. Chronic Candida lung colonization has also been associated with poorer lung function in cystic fibrosis patients 4.

Various animal studies have reported that combined lung infections involving both pathogenic bacteria (such as Staphylococcus aureus) and Candida have significantly higher mortality than infection with either pathogen alone 5. The authors concluded that much more research is needed to study lung infections involving both pathogenic bacteria and Candida. 1.

--------------

Assessment and Treatment of Fungal Lung Infections

https://www.uspharmacist.com/article/assessment-and-treatment-of-fungal-lung-infections

Invasive fungal infections occur in both immunocompetent and immunocompromised patients...

Candidiasis: Pulmonary pneumonia infection due to Candida species is rare and diagnosis can be difficult. Primary Candida pneumonia refers to an invasive infection in the lungs, while secondary pneumonia refers to dissemination of invasive candidiasis.1,12 Colonization of the lung parenchyma with Candida species is common; in critically ill patients, however, defense mechanisms are rendered ineffective, thus enabling penetration of lung tissue. Many critically ill patients are empirically treated with broad-spectrum antibiotics. Further clinical deterioration and lack of improvement in these cases suggest the initiation of empiric antifungal therapy. Because triazole antifungals and echinocandins exhibit excellent lung penetration, they—in addition to AmB formulations—are effective for treating pulmonary candidiasis, despite the lack of specific studies regarding the treatment of Candida pneumonia.12,13